Alzamend Neuro Inc. (ALZN)
Market Open
15 Jun, 14:14
NASDAQ (CM) NASDAQ (CM) Primary $
1. 23
+0.02
+1.6529%
$
3.8M Market Cap
- P/E Ratio
- Div Yield
30,526 Volume
- Eps
$ 1.21
Previous Close Want to track ALZN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alzamend Neuro Inc. (ALZN) Statistics
Valuation metrics
Market Cap 3.8M
Enterprise value 1.09M
Trailing P/E (ttm) -0.65
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 2.11
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.95K
Average volume (90 days) 123.13K
Price summary
52-Week low 0.84
52-Week high 3.6
Beta -
50-Day moving average 1.11
200-Day moving average 1.16
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:9
Last split Date 12 May 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.74%
Return on equity -1.77%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.85
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.71
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.99%
Book value per share (mrq) 0.57
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
